Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis

Affiliations

• ¹ Department I of Internal Medicine, Centre of Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
• ² German Hodgkin Study Group (GHSG), Cologne, Germany.
• ³ Medical Clinic I, University Hospital Dresden, Dresden, Germany.
• ⁴ University Hospital Duesseldorf, Duesseldorf, Germany.
• ⁵ Stuttgart General Hospital, Stuttgart, Germany.
• ⁶ Knappschaftskrankenhaus Bochum, Bochum, Germany.
• ⁷ Hämatologisch-onkologische Praxis Heinrich/Bangerter, Augsburg, Germany.
• ⁸ Brüderkrankenhaus St. Josef Paderborn, Paderborn, Germany.
• ⁹ Onkologie Rheinsieg, Troisdorf, Germany.
• ¹⁰ Onkologie Pasing, Munich, Germany.
• ¹¹ Hospital Schwarzwald-Baar, Villingen Schwenningen, Germany.
• ¹² Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
• ¹³ Klinikum Lüdenscheid, Germany.
• ¹⁴ St. Josefs-Hospital Hagen, Hagen, Germany.
• ¹⁵ Klinik für Innere Medizin C - Hämatologie, Onkologie, Stammzelltransplantation, Palliativmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.
• ¹⁶ Department of Hematology and Oncology, Medical Center, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
• ¹⁷ Dietrich-Bonhoeffer-Klinikum Neubrandenburg, Neubrandenburg, Germany.
• ¹⁸ Onkologie Magdeburg, Magdeburg, Germany.
• ¹⁹ Klinikum Oldenburg, Oldenburg, Germany.
• ²⁰ Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf (MSSO ABCD), Cologne, Germany.
• ²¹ Max Planck Institute for the Biology of Ageing, Cologne, Germany.